Therapeutic Asset Ratings
329 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dfn-15
Obesity Disorder
ARKAY Therapeutics
P1/2
CC
(45)
Gly-Low
Obesity Disorder
University of California, San Francisco
P1/2
CC
(45)
Inomax
Obesity
Vanderbilt University Medical Center
P1
CC
(44)
Solu-Cortef
Obesity Disorder
Eleonora Seelig
P1
CC
(44)
Lotiglipron
Obesity Disorder
Pfizer
P2
CC
(42)
bi 1820237
Obesity Disorder
Boehringer Ingelheim
P1
CC
(42)
Itraconazole
Obesity Disorder
Shionogi
P1
CC
(42)
Octreotide Pamoate
Obesity Disorder
Columbia University
P1
CC
(42)
Omeprazole
Obesity Disorder
Shandong Suncadia Medicine Co., Ltd.
P1
CC
(42)
ORSYTHIA COMPONENT ETHINYL ESTRADIOL
Obesity Disorder
Amgen
P1
CC
(42)
Omnipaque
Obesity Disorder
University of Colorado, Denver
P1/2
CC
(42)
pb-119
Obesity Disorder
PegBio Co., Ltd.
P1/2
CC
(42)
pb-718
Obesity Disorder
PegBio Co., Ltd.
P1/2
CC
(42)
SODIUM P-AMINOHIPPURATE
Obesity Disorder
University of Colorado, Denver
P1/2
CC
(42)
Angiotensin-(1-7)
Obesity Disorder
Milton S. Hershey Medical Center
P1
CC
(41)
DEXAMETHASONE
Obesity Disorder
University of North Carolina, Chapel Hill
P1
CC
(41)
Hrs-5817
Obesity Disorder
Atridia Pty Ltd.
P1
CC
(41)
Phentolamine
Obesity Disorder
University of Missouri-Columbia
P1
CC
(41)
PROPRANOLOL
Obesity Disorder
University of Missouri-Columbia
Early P1
CC
(40)
Aln-2232
Obesity Disorder
Alnylam Pharmaceuticals
P1/2
CC
(40)
Aro-Alk7
Obesity Disorder
Arrowhead Pharmaceuticals
P1/2
CC
(40)
Aro-Inhbe
Obesity Disorder
Arrowhead Pharmaceuticals
P1/2
CC
(40)
axp107-11
Obesity Disorder
Western University
P1/2
CC
(40)
Deltagold® Tocotrienol 70%
Obesity Disorder
Texas Tech University Health Sciences Center
P1/2
CC
(40)
Amg 786
Obesity Disorder
Amgen
P1
C
(39)
Showing 201 to 225 of 329 assets
Previous
Page 9 of 14
Next
